Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% | -.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Performance
1 day | -25.00% | ||
1 year | -30.77% | ||
3 years | -67.86% | ||
5 years | -70.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-25.00% | -.--% | -.--% | -30.77% | 2.99M | ||
-5.89% | -14.43% | +43.36% | +10.93% | 54.63B | ||
-1.51% | -4.58% | -5.31% | +10.11% | 39.92B | ||
-0.45% | -5.59% | +37.52% | -15.53% | 38.82B | ||
+0.59% | +1.28% | +14.75% | +50.48% | 26.86B | ||
-0.62% | -2.06% | -12.56% | +0.46% | 26.22B | ||
-1.07% | +0.45% | -22.45% | -21.33% | 18.78B | ||
+1.73% | +0.82% | +25.12% | +28.88% | 12.21B | ||
-0.08% | -4.46% | +0.04% | -5.51% | 12.16B | ||
+0.17% | -1.08% | +26.04% | +86.74% | 11.94B | ||
-0.61% | -4.04% | -11.83% | +6.16% | 10.74B | ||
+1.45% | -1.07% | -3.38% | -8.34% | 9.6B | ||
-1.82% | -6.48% | +24.38% | -13.99% | 6.71B | ||
-0.75% | +2.67% | +14.44% | +85.88% | 6.61B | ||
+0.42% | +1.00% | +33.65% | +52.10% | 6.32B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | -2.09% | -2.34% | +10.92% | +15.75% | ||
Weighted average by Cap. | -1.41% | -4.61% | +14.88% | +12.35% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2023 | -35.71% | ||
2022 | -.--% | ||
2021 | -36.36% | ||
2020 | -26.67% | ||
2019 | +500.00% | ||
2018 | -75.00% | ||
2017 | -71.43% | ||
2016 | +40.00% | ||
2015 | -.--% |
- Stock Market
- Equities
- FNAM Stock
- Quotes Evolutionary Genomics, Inc.